{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:28:28Z","timestamp":1790155708689,"version":"4.0.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T00:00:00Z","timestamp":1390780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0087054","type":"journal-article","created":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T21:43:20Z","timestamp":1390859000000},"page":"e87054","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":37,"title":["Increased Arterial Diameters in the Posterior Cerebral Circulation in Men with Fabry Disease"],"prefix":"10.1371","volume":"9","author":[{"given":"Nurcan","family":"\u00dc\u00e7eyler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy A.","family":"Homola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Guerrero Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Weidemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Solymosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2009.01.003","article-title":"Fabry disease","volume":"122","author":"R Schiffmann","year":"2009","journal-title":"Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.ATV.0000209649.60409.38","article-title":"Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition","volume":"26","author":"F Barbey","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"RJ Desnick","year":"2003","journal-title":"Ann Intern Med"},{"key":"ref4","first-page":"615218","article-title":"Fabry disease and early stroke","volume":"2011","author":"U Feldt-Rasmussen","year":"2011","journal-title":"Stroke Res Treat"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1212\/01.wnl.0000173030.70057.eb","article-title":"White matter lesion severity in male and female patients with Fabry disease","volume":"65","author":"A Fellgiebel","year":"2005","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainresbull.2003.09.021","article-title":"White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions","volume":"62","author":"DF Moore","year":"2003","journal-title":"Brain Res Bull"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","article-title":"Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry","volume":"40","author":"K Sims","year":"2009","journal-title":"Stroke"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/STROKEAHA.112.663708","article-title":"Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients study","volume":"44","author":"A Rolfs","year":"2013","journal-title":"Stroke"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00415-004-0364-9","article-title":"Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease","volume":"251","author":"MJ Hilz","year":"2004","journal-title":"J Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/hs0202.102601","article-title":"Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement","volume":"33","author":"DF Moore","year":"2002","journal-title":"Stroke"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.7863\/jum.2012.31.3.463","article-title":"Cerebral blood flow in patients with Fabry disease as measured by Doppler sonography is not different from that in healthy individuals and is unaffected by treatment","volume":"31","author":"N \u00dc\u00e7eyler","year":"2012","journal-title":"J Ultrasound Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1212\/01.wnl.0000338566.54190.8a","article-title":"Diagnostic utility of different MRI and MR angiography measures in Fabry disease","volume":"72","author":"A Fellgiebel","year":"2009","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000322558","article-title":"Basilar artery diameter is a potential screening tool for Fabry disease in young stroke patients","volume":"31","author":"A Fellgiebel","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1529-8027.2011.00365.x","article-title":"Small fibers in Fabry disease: baseline and follow-up data under enzyme replacement therapy","volume":"16","author":"N \u00dc\u00e7eyler","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","article-title":"Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy","volume":"24","author":"R Schiffmann","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1681\/ASN.2006121400","article-title":"Antiproteinuric Therapy and Fabry Nephropathy: Sustained Reduction of Proteinuria in Patients Receiving Enzyme Replacement Therapy with Agalsidase-beta","volume":"18","author":"H Tahir","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.1371\/journal.pone.0000598","article-title":"Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg\/kg","volume":"2","author":"AC Vedder","year":"2007","journal-title":"PLoS ONE"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging","volume":"149","author":"F Fazekas","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/brain\/awh546","article-title":"Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the alpha-galactosidase A gene","volume":"128","author":"F Garzuly","year":"2005","journal-title":"Brain"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410400105","article-title":"Cerebrovascular complications of Fabry's disease","volume":"40","author":"P Mitsias","year":"1996","journal-title":"Ann Neurol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/hc3801.096352","article-title":"Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy","volume":"104","author":"DF Moore","year":"2001","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/jmri.20162","article-title":"Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: an arterial spin tagging study","volume":"20","author":"DF Moore","year":"2004","journal-title":"J Magn Reson Imaging"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1552-6569.2001.tb00051.x","article-title":"Selective arterial distribution of cerebral hyperperfusion in Fabry disease","volume":"11","author":"DF Moore","year":"2001","journal-title":"J Neuroimaging"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/jnnp.36.6.1053","article-title":"Anderson-Fabry disease: a histopathological study of three cases with observations on the mechanism of production of pain","volume":"36","author":"P Kahn","year":"1973","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ana.410230513","article-title":"Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation","volume":"23","author":"EM Kaye","year":"1988","journal-title":"Ann Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1212\/01.wnl.0000313367.09469.13","article-title":"Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease","volume":"70","author":"P Laforet","year":"2008","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Franzen D, Krayenbuehl PA, Lidove O, Aubert JD, Barbey F (2013) Pulmonary involvement in Fabry disease: Overview and perspectives. Eur J Intern Med.","DOI":"10.1016\/j.ejim.2013.05.003"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/WNL.50.6.1746","article-title":"Quantitative analysis of cerebral vasculopathy in patients with Fabry disease","volume":"50","author":"KE Crutchfield","year":"1998","journal-title":"Neurology"},{"key":"ref29","unstructured":"Ginsberg L (2006) Nervous system manifestations of Fabry disease: data from FOS - the Fabry Outcome Survey. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/clc.22047","article-title":"Arrhythmias in Fabry cardiomyopathy","volume":"35","author":"D Acharya","year":"2012","journal-title":"Clin Cardiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1440-1789.2008.00883.x","article-title":"An autopsy case of Fabry disease with neuropathological investigation of the pathogenesis of associated dementia","volume":"28","author":"R Okeda","year":"2008","journal-title":"Neuropathology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e60304","DOI":"10.1371\/journal.pone.0060304","article-title":"Brainstem involvement as a cause of central sleep apnea: pattern of microstructural cerebral damage in patients with cerebral microangiopathy","volume":"8","author":"T Duning","year":"2013","journal-title":"PLoS ONE"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1023\/B:BOLI.0000028794.04349.91","article-title":"CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy","volume":"27","author":"L Jardim","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/jnnp.2006.112987","article-title":"Voxel based analyses of diffusion tensor imaging in Fabry disease","volume":"78","author":"J Albrecht","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1148\/radiol.2412051122","article-title":"Subcortical damage and cortical functional changes in men and women with Fabry disease: a multifaceted MR study","volume":"241","author":"C Gavazzi","year":"2006","journal-title":"Radiology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000337906","article-title":"Functional transcranial Doppler: presymptomatic changes in Fabry disease","volume":"67","author":"E Azevedo","year":"2012","journal-title":"Eur Neurol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0087054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T17:23:08Z","timestamp":1589044988000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0087054"}},"subtitle":[],"editor":[{"given":"Raphael","family":"Schiffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,27]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0087054","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,27]]}}}